Ditazole: Difference between revisions
Content deleted Content added
cat |
Bwthemoose (talk | contribs) added text and ref |
||
| Line 24: | Line 24: | ||
| routes_of_administration = |
| routes_of_administration = |
||
}} |
}} |
||
'''Ditazole''' is a [[platelet]] aggregation [[inhibitor]]. |
'''Ditazole''' is a [[platelet]] aggregation [[inhibitor]]. |
||
== References == |
== References == |
||
{{ reflist}} |
|||
{{refbegin}} |
{{refbegin}} |
||
* The Merck Index, 12th Edition. 3432 |
* The Merck Index, 12th Edition. 3432 |
||
Revision as of 18:51, 28 November 2007
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.038.488 |
| Chemical and physical data | |
| Formula | C19H20N2O3 |
| Molar mass | 324.374 g/mol g·mol−1 |
Ditazole is a platelet aggregation inhibitor.It is marketed in Spain and Portugal under the trade name Ageroplas.[1]
References
- ^ Martindale's Complete Drug Reference,http://www.medicinescomplete.com/mc/martindale/current/2639-d.htm
- The Merck Index, 12th Edition. 3432
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |